PT-141vsTesamorelin
PT-141 vs Tesamorelin — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A melanocortin receptor agonist that works through the central nervous system to improve sexual arousal. FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
PT-141 vs Tesamorelin: At a Glance
Full comparison across all key factors.
| Factor | PT-141ALLY PICK | Tesamorelin |
|---|---|---|
| Category | sexual-health | growth-hormone |
| Also Known As | Bremelanotide, Vyleesi | Egrifta |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Prescription | Required | Required |
| Providers | 5 providers✓ Better | 4 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
3 providers offer both PT-141 and Tesamorelin.
| Provider | PT-141 | Tesamorelin | Consultation | Lab Testing |
|---|---|---|---|---|
 | $150/per-vial | $350/monthly | Video Telehealth | Yes |
 | $160/monthly | $380/monthly | Video Telehealth | Yes |
 | $200/monthly | $420/monthly | Video Telehealth | Yes |
 | $30/one-time | Not offered | Async Telehealth | No |
 | $140/monthly | Not offered | Video Telehealth | No |
 | Not offered | $349/monthly | Async Telehealth | Yes |
Key Differences
PT-141
More ProvidersA melanocortin receptor agonist that works through the central nervous system to improve sexual arousal. FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
Tesamorelin
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Which Is Right for You?
Choose PT-141if…
- You want a sexual-health medication
- You prefer subcutaneous injection administration
- You want more provider options (5 available)
- Your primary goal is sexual dysfunction
- Your primary goal is low libido
Choose Tesamorelinif…
- You want a growth-hormone medication
- You prefer subcutaneous injection administration
- 4 providers available on our platform
- Your primary goal is visceral fat reduction
- Your primary goal is growth hormone stimulation
Frequently Asked Questions
What is the difference between PT-141 and Tesamorelin?
Which is cheaper, PT-141 or Tesamorelin?
Can I switch from PT-141 to Tesamorelin?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.